Current and Future Generic Prescription Drugs: Global Market Analysis

Published by: PJB Publications USA Inc.

Published: Sep. 1, 2003 - 237 Pages

Table of Contents

• 1.1 Scope and Objectives of Report
  
• 1.2 Methodology

2 Overview of the Generic Drug Market

• 2.1 History of the Generic Drug Market
  
• 2.2 History of the Generic Drug Approval Process
  
• 2.3 The Drug Approval Process

3 Generic Anti-Infectives

• 3.1 Overview
  
• 3.2 Conditions and Drug Products
  
• 3.2.1 Antibiotics and Antibacterial Agents
  
• 3.2.2 Antiviral Drugs
  
• 3.2.3 Antifungal Drugs
  
• 3.2.4 Antimalarial Drugs
  
• 3.2.5 Antiparasitic Drugs
  
• 3.2.6 Drugs to Treat Tuberculosis
  
• 3.2.7 Other Topical Anti-Infectives
  
• 3.3 Market Size and Growth
  
• 3.3.1 Total World Market
  
• 3.3.2 U.S. Mark
  
• 3.3.3 Rest of World Market
  
• 3.4 Competitor An

4 Generic Cancer Drugs

• 4.1 Overview
  
• 4.2 Conditions and Drug Products
  
• 4.2.1 Alkylating Cancer Drugs
  
• 4.2.2 Antimetabolite Cancer Drugs
  
• 4.2.3 Mitotic Inhibitor Cancer Drugs
  
• 4.2.4 Antineoplastic Antibiotic Cancer Drugs
  
• 4.2.5 Antineoplastic Hormone and Other Cancer Drugs
  
• 4.3 Market Size and Growth
  
• 4.3.1 Total World Market
  
• 4.3.2 U.S. Mark
  
• 4.3.3 Rest of World Market
  
• 4.4 Competitor An

5 Generic Cardiovascular Drugs

• 5.1 Overview
  
• 5.2 Conditions and Drug Products
  
• 5.2.1 ACE Inhibitors
  
• 5.2.2 Antiarrhythmia Drugs
  
• 5.2.3 Antihyperlipidemic Drugs
  
• 5.2.4 Adrenergic Blockers
  
• 5.2.5 Calcium Channel Blockers
  
• 5.2.6 Diuretics
  
• 5.2.7 Vasodilators
  
• 5.3 Market Size and Growth
  
• 5.3.1 Total World Market
  
• 5.3.2 U.S. Mark
  
• 5.3.3 Rest of World Market
  
• 5.4 Competitor An

6 Generic Central Nervous System Drugs

• 6.1 Overview
  
• 6.2 Conditions and Drug Products
  
• 6.2.1 CNS St
  
• 6.2.2 Antidepressants and Antimanic Agents
  
• 6.2.3 Antianxiety, Sedative, and Hypnotic Drugs
  
• 6.2.4 Antipsychotics
  
• 6.2.5 Anticonvulsants, Antispasmodics, and Muscle Relaxants
  
• 6.2.6 Parkinson’s Disease and Myasthenia Gravis Treatment Drugs
  
• 6.2.7 Analgesics and Anesthetics
  
• 6.3 Market Size and Growth
  
• 6.3.1 Total World Market
  
• 6.3.2 U.S. Ma
  
• 6.3.3 Rest of World Market
  
• 6.4 Competitor

7 Generic Gastrointestinal Drugs

• 7.1 Overview
  
• 7.2 Conditions and Drug Products
  
• 7.2.1 Histamine H2 Antagonists
  
• 7.2.2 Proton Pump Inhibitors
  
• 7.2.3 Antidiarrheals and Antispasmodics
  
• 7.2.4 Antiemetic Drugs
  
• 7.3 Market Size and Growth
  
• 7.3.1 Total World Market
  
• 7.3.2 U.S. Ma
  
• 7.3.3 Rest of World Market
  
• 7.4 Competitor

8 Generic Hormone, Endocrine, and Metabolic Disorder Drugs

• 8.1 Overview
  
• 8.2 Conditions and Drug Products
  
• 8.2.1 Diabetes Treatment Drugs
  
• 8.2.2 Female and Male Sex Hormones
  
• 8.2.3 Thyroid Hormones
  
• 8.2.4 Corticosteroids for Relevant Conditions
  
• 8.3 Market Size and Growth
  
• 8.3.1 Total World Market
  
• 8.3.2 U.S. Ma
  
• 8.3.3 Rest of World Market
  
• 8.4 Competitor

9 Generic Respiratory and Allergy Drugs

• 9.1 Overview
  
• 9.2 Conditions and Drug Products
  
• 9.2.1 Antihistamines and Decongestants
  
• 9.2.2 Bronc
  
• 9.2.3 Inhaled Corticosteroids and Antiasthmatic Agents
  
• 9.2.4 Cough Suppressants/Expectorants
  
• 9.3 Market Size and Growth
  
• 9.3.1 Total World Market
  
• 9.3.2 U.S. Ma
  
• 9.3.3 Rest of World Market
  
• 9.4 Competitor

10 Overall Market Summary

11 Generic Drug Industry Issues and Trends

• 11.1 Patent Legislation
  
• 11.2 Antitrust Agreements
  
• 11.3 Prescription Drugs for Senior Citizens
  
• 11.4 Generic Biologics

12 Company Profiles

• 12.1 Alpharma, Inc.
  
• 12.2 Andrx Corp
  
• 12.3 Barr Laboratories, Inc
  
• 12.4 Falcon Pharmaceuticals, Ltd.
  
• 12.5 Geneva Pharmaceuticals, Inc
  
• 12.6 IVAX Corp.
  
• 12.7 KV Pharmaceutical Co.
  
• 12.8 Mylan Laboratories, Inc.
  
• 12.9 Ranbaxy Laboratories Ltd.
  
• 12.10 Roxane Laboratories, Inc
  
• 12.11 Sicor, Inc.
  
• 12.12 Teva Pharmaceutical Industries Ltd.
  
• 12.13 Watson Pharmaceuticals, Inc

13 Company Directory

Abstract

According to the U.S. Congressional Budget Office, generic drugs save consumers an estimated $8 to $10 billion per year at retail pharmacies. Even more billions are saved when hospitals use generics.

In order to help your organization make educated decisions in this rapidly expanding market, Theta’s study is designed to provide the reader with an overall view of generic drugs, their manufacturers, market figures, competitor market shares, recent and upcoming approvals, issues affecting the market and other valuable information.

Product segments covered in this report include:

• Anti-Infectives
• Cancer Drugs
• Cardiovascular Drugs
• Central Nervous System Drugs
• Gastrointestinal Drugs
• Hormone, Endocrine, and Metabolic Disease Drugs
• Respiratory Drugs and Allergy Treatments

Please Note: Theta requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 200,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.